Chinese Stock Message Board

Stock discussion boards for Japanese, US and Chinese stocks

日本語English简体中文 繁體中文

HOME Monologue Trades Monthly Annual Dividends Stock Assets Total Assets Stock Lending IPO FUNDINNO Indicators Market Daily JP Stock Blog CN Stock Blog US Stock Blog JP Curated Dividends US Curated Dividends CN Curated Dividends 日本株テンバガー候補 JP Top 50 Gainers JP Top 50 Losers JP Stock Board US Stock Board CN Stock Board J-REIT Ranking J-REIT Guide High-Div Funds Yutai Benefits Premium Yutai Club Nikkei A/D Ratio Growth A/D Ratio Investor Flows JP Disclosures US Disclosures CN Disclosures Amazonおすすめ Amazonタイムセール Kabutaro on X

688266 Suzhou Zelgen Biopharmaceuticals Co., Ltd.泽璟制药Shanghai Stock Exchange

3 posts

Price chart ・ Find other stocks ・ Japanese version

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266) at a glance

Code
688266
Company
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Local name
泽璟制药
Market
Shanghai Stock Exchange
Share price
CN¥94.00 -9.81 (-9.45%) Oct 27 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266) Stock Price History

Suzhou Zelgen Biopharmaceuticals Co., Ltd. closed at CN¥94.00 on Oct 27, 2026, −13.7% over 1 month, −7.9% over 1 year.

2026-10-14 上場・売買開始 泽璟制药关于自愿披露盐酸吉卡昔替尼片治疗活动性强直性脊柱炎的新药…2026-10-21 契約の締結 泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收…2026-10-24 新薬・製品の承認 泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成…CN¥110.00CN¥94.00Sep 28Oct 27
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥110.00Sep 30
1-Month LowCN¥94.00Oct 27
1-Week Change−7.4%vs Oct 20
1-Month Change−13.7%vs Sep 24

If you had invested CN¥10,000 1 month ago, it would be worth CN¥8,772 today (−12.3%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.6%, while this stock moved −12.3%.

Last 10 Trading Days

DateCloseChange% Change
Oct 27 (Tue)CN¥94.00−9.81−9.45%
Oct 26 (Mon)CN¥103.81+0.06+0.06%
Oct 23 (Fri)CN¥103.75+4.25+4.27%
Oct 22 (Thu)CN¥99.50−3.06−2.98%
Oct 21 (Wed)CN¥102.56+1.06+1.04%
Oct 20 (Tue)CN¥101.50−0.50−0.49%
Oct 19 (Mon)CN¥102.00+5.34+5.52%
Oct 16 (Fri)CN¥96.66+1.66+1.75%
Oct 15 (Thu)CN¥95.00−1.60−1.66%
Oct 14 (Wed)CN¥96.60−2.40−2.42%
2026-10-14 上場・売買開始 泽璟制药关于自愿披露盐酸吉卡昔替尼片治疗活动性强直性脊柱炎的新药…2026-10-21 契約の締結 泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收…2026-10-24 新薬・製品の承認 泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成…CN¥139.21CN¥94.00Jul 27Oct 27
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥139.21Jul 27
3-Month LowCN¥94.00Oct 27
1-Month Change−13.7%vs Sep 24
3-Month Change−32.5%vs Jul 27

If you had invested CN¥10,000 3 months ago, it would be worth CN¥6,752 today (−32.5%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −5.4%, while this stock moved −32.5%.

Last 10 Trading Days

DateCloseChange% Change
Oct 27 (Tue)CN¥94.00−9.81−9.45%
Oct 26 (Mon)CN¥103.81+0.06+0.06%
Oct 23 (Fri)CN¥103.75+4.25+4.27%
Oct 22 (Thu)CN¥99.50−3.06−2.98%
Oct 21 (Wed)CN¥102.56+1.06+1.04%
Oct 20 (Tue)CN¥101.50−0.50−0.49%
Oct 19 (Mon)CN¥102.00+5.34+5.52%
Oct 16 (Fri)CN¥96.66+1.66+1.75%
Oct 15 (Thu)CN¥95.00−1.60−1.66%
Oct 14 (Wed)CN¥96.60−2.40−2.42%
2026-10-14 上場・売買開始 泽璟制药关于自愿披露盐酸吉卡昔替尼片治疗活动性强直性脊柱炎的新药…2026-10-21 契約の締結 泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收…2026-10-24 新薬・製品の承認 泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成…CN¥147.40CN¥87.00Apr 27Oct 27
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥147.40Jul 14
6-Month LowCN¥87.00Jun 17
3-Month Change−32.5%vs Jul 27
6-Month Change−6.0%vs Apr 27

If you had invested CN¥10,000 6 months ago, it would be worth CN¥9,400 today (−6.0%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −10.7%, while this stock moved −6.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026CN¥94.00−14.5%
Sep 2026CN¥110.00−6.5%
Aug 2026CN¥117.59−3.7%
Jul 2026CN¥122.10+4.7%
Jun 2026CN¥116.66+16.7%
May 2026CN¥99.93−3.9%
Apr 2026CN¥104.00+5.3%
2026-10-14 上場・売買開始 泽璟制药关于自愿披露盐酸吉卡昔替尼片治疗活动性强直性脊柱炎的新药…2026-10-21 契約の締結 泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收…2026-10-24 新薬・製品の承認 泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成…CN¥147.40CN¥75.75Oct 27Oct 27
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥147.40Jul 14
52-Week LowCN¥75.75Mar 4
Year to Date+1.4%vs Dec 31
From 52-Week High−36.2%Jul 14

If you had invested CN¥10,000 1 year ago, it would be worth CN¥9,215 today (−7.9%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −8.7%, while this stock moved −7.9%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026CN¥94.00−14.5%
Sep 2026CN¥110.00−6.5%
Aug 2026CN¥117.59−3.7%
Jul 2026CN¥122.10+4.7%
Jun 2026CN¥116.66+16.7%
May 2026CN¥99.93−3.9%
Apr 2026CN¥104.00+5.3%
Mar 2026CN¥98.80+20.3%
Feb 2026CN¥82.12−6.8%
Jan 2026CN¥88.12−4.9%
Dec 2025CN¥92.70−15.7%
Nov 2025CN¥110.00+5.9%
Oct 2025CN¥103.88―
CN¥145.00CN¥37.83Oct 30, 2023Oct 27, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥145.00Jul 10, 2026
3-Year LowCN¥37.83Jan 29, 2024
Annualized Return+27.8%
Max Drawdown−40.9%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥20,856 today (+108.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +20.4%, while this stock moved +108.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥94.00+1.4%
2025CN¥92.70―
CN¥145.00CN¥26.01Nov 1, 2021Oct 27, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥145.00Jul 10, 2026
5-Year LowCN¥26.01Apr 25, 2022
Annualized Return+8.6%
Max Drawdown−61.0%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥15,079 today (+50.8%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +4.5%, while this stock moved +50.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥94.00+1.4%
2025CN¥92.70―
CN¥145.00CN¥26.01Jan 20, 2020Oct 27, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥145.00Jul 2026
All-Time LowCN¥26.01Apr 2022
Total Change+26.0%vs Jan 2020
Annualized Return+3.5%

If you had invested CN¥10,000 in Jan 2020, it would be worth CN¥12,602 today (+26.0%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +22.6%, while this stock moved +26.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥94.00+1.4%
2025CN¥92.70+50.5%
2024CN¥61.58+16.3%
2023CN¥52.94+27.0%
2022CN¥41.70−29.1%
2021CN¥58.80−9.1%
2020CN¥64.69―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2020). Please check the latest prices before trading.

Recent announcements (CNINFO, in Chinese)

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.3 Disclosure 2026/10/24 09:00
新薬・製品の承認
泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成首例受试者入组的公告

📄 Open the filing

Delete
No.2 Disclosure 2026/10/21 09:00
契約の締結
泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收到里程碑付款的公告

📄 Open the filing

Delete
No.1 Disclosure 2026/10/14 09:00
上場・売買開始
泽璟制药关于自愿披露盐酸吉卡昔替尼片治疗活动性强直性脊柱炎的新药上市申请获得受理的公告

📄 Open the filing

Delete

Write on the Suzhou Zelgen Biopharmaceuticals Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English